Close

Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $152.00 (+164.1%) * Over Last 12-Mos
Rating Score: 4.4 / 10   Percentile Rank: 45%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2015 Goldman Sachs N/A New Coverage Neutral
(N/A)
65.00
(N/A)
61.32
(57.56)
-6.13% Details
9/22/2015 Barclays N/A New Coverage Equalweight
(N/A)
60.00
(N/A)
50.20
(57.56)
14.66% Details